JPS61138164A - 免疫凝集反応に用いるラテツクスの製造方法 - Google Patents
免疫凝集反応に用いるラテツクスの製造方法Info
- Publication number
- JPS61138164A JPS61138164A JP26155084A JP26155084A JPS61138164A JP S61138164 A JPS61138164 A JP S61138164A JP 26155084 A JP26155084 A JP 26155084A JP 26155084 A JP26155084 A JP 26155084A JP S61138164 A JPS61138164 A JP S61138164A
- Authority
- JP
- Japan
- Prior art keywords
- latex
- emulsifier
- polystyrene particles
- styrene
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004816 latex Substances 0.000 title claims abstract description 120
- 229920000126 latex Polymers 0.000 title claims abstract description 120
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 53
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 239000002245 particle Substances 0.000 claims abstract description 88
- 239000004793 Polystyrene Substances 0.000 claims abstract description 64
- 229920002223 polystyrene Polymers 0.000 claims abstract description 64
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 52
- 230000005484 gravity Effects 0.000 claims abstract description 22
- 238000005660 chlorination reaction Methods 0.000 claims abstract description 18
- 239000000725 suspension Substances 0.000 claims abstract description 17
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 31
- 238000006116 polymerization reaction Methods 0.000 claims description 20
- 238000004220 aggregation Methods 0.000 claims description 17
- 230000002776 aggregation Effects 0.000 claims description 14
- 239000003505 polymerization initiator Substances 0.000 claims description 11
- 230000000379 polymerizing effect Effects 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 abstract description 18
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 14
- 239000003999 initiator Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 239000000427 antigen Substances 0.000 description 18
- 102000036639 antigens Human genes 0.000 description 18
- 108091007433 antigens Proteins 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 230000004520 agglutination Effects 0.000 description 16
- 239000012153 distilled water Substances 0.000 description 12
- 238000000502 dialysis Methods 0.000 description 9
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 229910001873 dinitrogen Inorganic materials 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 210000000601 blood cell Anatomy 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000010926 purge Methods 0.000 description 5
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 230000035931 haemagglutination Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 238000011891 EIA kit Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000012874 anionic emulsifier Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- -1 antisera Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010556 emulsion polymerization method Methods 0.000 description 2
- 238000007720 emulsion polymerization reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000012875 nonionic emulsifier Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229940054541 urex Drugs 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polymerisation Methods In General (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26155084A JPS61138164A (ja) | 1984-12-10 | 1984-12-10 | 免疫凝集反応に用いるラテツクスの製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26155084A JPS61138164A (ja) | 1984-12-10 | 1984-12-10 | 免疫凝集反応に用いるラテツクスの製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61138164A true JPS61138164A (ja) | 1986-06-25 |
| JPH0527825B2 JPH0527825B2 (enrdf_load_stackoverflow) | 1993-04-22 |
Family
ID=17363452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP26155084A Granted JPS61138164A (ja) | 1984-12-10 | 1984-12-10 | 免疫凝集反応に用いるラテツクスの製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61138164A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011148860A (ja) * | 2010-01-19 | 2011-08-04 | Sekisui Plastics Co Ltd | 重合体粒子、及びその製造方法、電子写真トナー用外添剤 |
-
1984
- 1984-12-10 JP JP26155084A patent/JPS61138164A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011148860A (ja) * | 2010-01-19 | 2011-08-04 | Sekisui Plastics Co Ltd | 重合体粒子、及びその製造方法、電子写真トナー用外添剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0527825B2 (enrdf_load_stackoverflow) | 1993-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4605686A (en) | Latex for immunoserological tests and a method for the production of the same | |
| AU2002313319B2 (en) | Carrier particle latex for assay reagent and assay reagent | |
| AU608753B2 (en) | Dispersion polymers, processes for their preparation and their use | |
| EP0372413B1 (de) | Mittel für immunchemische Tests, carboxylgruppenhaltige Polymere enthaltend | |
| JPH05310849A (ja) | 多官能性親水性球状微粒子、その製造方法及びその使用方法 | |
| JPH04233924A (ja) | ポリオキシアルキレン側鎖含有共重合体 | |
| JPS61138164A (ja) | 免疫凝集反応に用いるラテツクスの製造方法 | |
| JP5348724B2 (ja) | 抗リン脂質抗体測定試薬に用いる不溶性担体、抗リン脂質抗体測定試薬、及び、抗リン脂質抗体の測定方法 | |
| JPH02257063A (ja) | 免疫測定試薬および免疫測定法 | |
| JPH0640099B2 (ja) | 免疫凝集反応に用いるための担体 | |
| JPH04265860A (ja) | 免疫測定検査用凝集判定プレート | |
| JPS60233105A (ja) | 診断試薬用ラテツクスの製造方法 | |
| JPS60258207A (ja) | 診断試薬用ラテックス | |
| JPS5850646B2 (ja) | 血清学的診断試薬用ラテツクスの製造方法 | |
| JPS5850645B2 (ja) | ラテツクスの製造方法 | |
| EP0286687B1 (en) | Carrier latex for diagnostic reagent | |
| JPS60192706A (ja) | 診断試薬用ラテツクスの製造方法 | |
| JPH0157687B2 (enrdf_load_stackoverflow) | ||
| JPS62218867A (ja) | 免疫試薬用ラテツクス | |
| US5183766A (en) | Dispersion polymers, processes for their preparation and their use | |
| JPH0745524B2 (ja) | 診断試薬用塩化ビニル重合体ラテックスおよびその製造方法 | |
| JPH01266111A (ja) | 含フッ素ポリマーラテックス及びその用途 | |
| JPS6116943B2 (enrdf_load_stackoverflow) | ||
| JPH0745525B2 (ja) | 診断試薬用塩化ビニル重合体ラテックスおよびその製造方法 | |
| JPH0136485B2 (enrdf_load_stackoverflow) |